Citywire for Financial Professionals
Stay connected:

View the article online at

Investors reject Woodford's call for more money

(Update) Volatile markets force star fund manager Neil Woodford to shelve plans for further fund raising for Patient Capital trust.

Investors reject Woodford's call for more money

(Update) Woodford Patient Capital Trust (WPCT ) has postponed plans for a new share issue after investors rejected an appeal by fund manager Neil Woodford to back a further round of investments in early stage healthcare and technology companies.

Releasing the investment trust’s first annual results chairman Susan Searle said: ‘With the continuing uncertainty prevailing in markets, now is not an appropriate time to raise capital. The board will, however, monitor the situation and advise shareholders of any developments.’

This is a setback for Woodford who raised a record £800 million last year after the star fund manager excited investors with his vision of a low-charging, high performance fund backing British scientific innovation.

Shock call

In January, having become fully invested ahead of schedule, the trust surprised investors in the midst of a New Year market meltdown with a proposal to raise more money and tap what Woodford claimed was a bigger investment opportunity than he had previously thought.

Despite the Citywire AAA-rated manager’s strong track record, that was a step too far and with many investors pulling money from other funds the appetite for a ‘C-share’ issue that could have undermined an already weak share price simply wasn’t there.

According to a survey by Woodford Investment Management just over half of shareholders in the trust said they were prepared to invest more money in its shares over the next 12 months and understood why the manager wanted to raise more funds.

However, a majority also told the company they did not understand what a C-share issue was, and were lukewarm about participating in the offer.

Low charge, no return

Today’s results show that from its launch in April until the end of 2015 its net asset value fell 2.6% to 97.38p per share, which compared well with the 7.5% decline in the FTSE All Share. This year, however, the situation has reversed with the portfolio down 8.8% compared to a 0.5% dip in the index.

Since listing at 100p the shares have fallen around 12% and trade at 88.5p, a 0.8% discount below the NAV, according to Numis Securities.

However, at the height of investor enthusiasm in August the shares peaked at 120p, a premium of 15% above the then NAV. The unravelling of the premium means that anyone who bought the shares six months ago has suffered a 22% capital loss.

There is some consolation for shareholders in that they have paid very little to Woodford for their investment. The trust levied an on-going charge of just 0.1% in 2015 and did not come close to the 10% portfolio return required for it to earn its performance fee.

Dividend surprise

In another surprise, investors will also receive a small 0.16p per share dividend as the company distributes excess investment income in order to retain its investment trust status.

That dividend is unlikely to be repeated soon as Woodford is reducing the amount of dividend-paying larger companies the trust holds and increasing the proportion of non-dividend paying start-ups.

The annual report discloses the initial 25%/25%/50% split between mid-large cap stocks, early growth companies and early-stage companies has shifted. Its investment policy is now to hold between 15-30% in both the larger and early growth categories with 40-70% in early-stage businesses.

It currently holds just under 23% in large caps, 27% in early growth and 53% in early stage firms, according to the Woodford Investment Management website. Sixty per cent of the portfolio is in publicly traded companies quoted on a stock exchange, with just over 40% in private unlisted companies such as British university spin-offs Oxford Nanopore and Proton Partners, which are harder to trade and more difficult to value but which Woodford believes have exciting potential.

Patient plea

In his manager’s statement Woodford urged shareholders to be patient, saying the fundamental performance of most of the trust’s holdings, such as biotechs Prothena (PRTA.O) and Vernalis (VER), had been better than expected, even if this was not reflected in their valuations.

‘The stock market is not well-endowed with patience, particularly in volatile conditions. Periodically, this manifests itself in share price weakness, especially in businesses with no earnings or dividends and relatively limited market liquidity, but therein lies the opportunity for patient capital to exploit,’ he wrote.

Its worst performing investment so far is Northwest Biotherapeutics (NWBO.O), the US cancer treatment specialist whose shares have been damaged by anonymous allegations of financial irregularities. Since 30 June its weighting in the fund has plunged from 4% to 1%. In response to pressure from Woodford the company appointed two non-executive directors last year who have overseen an inquiry, whose findings have yet to be published.

In a video on his company’s website, Woodford acknowledged that the current market was difficult but expressed his confidence that a more ‘discerning’ market would arise later this year.

‘We’re very pleased with the portfolio,’ he added. ‘It’s taken a bit of a knock in the short term which has been reflected in the NAV coming down in the short term but we’re very confident where it will be in the next three to five years.’

4 comments so far. Why not have your say?


Mar 22, 2016 at 11:32

Further fund raising sends the share price down and means no management fee. I think Mr Woodford is finally realising this.

report this

Anonymous 1 needed this 'off the record'

Mar 22, 2016 at 17:25

Even if there is potential out there for pretty any one who has the courage to make an investment, I can accept how the markets are rattled. Today a bombing, potential Brexit, European chaos, Trump on the cards... although a wet dream for investment potential, even I got to say I feel the edge when making an investment however much sound it is.

Anyhow, in his case he should like he is wait it out instead of jumping the gun by showing return on investment... Such things take time & life is long, 800mil is at least something to work on in the first place.

report this

Anonymous 2 needed this 'off the record'

Mar 23, 2016 at 21:28

isnt there always "continuing uncertainty in markets"?

isnt it best to invest now because when there is no uncertainty prices will be higher?

as mr buffet says-you pay a high price for a cheery consensus.

report this

Anonymous 1 needed this 'off the record'

Mar 23, 2016 at 23:06

Yeh of course, but you can select smart even though the people are running away from the stocks doesn't mean you should pump money into them. There has been a lot of cheap money sloshing around, large debts and overvaluations & predictable results... even after a 'correction' which has just started one has to cherry pick.

Either how not disagreeing with you and am interested in what you see, just saying that Woodford made his choices & investor appetite isn't going to be strong for a second round when he hasn't shown the goods and people scared for their lives after a recent bombing amongst other things.

In any case, I personally see his request for money as a problem associated with gambling rather than an investing discipline, these prices aren't running away any time soon and was in the coming.

report this

leave a comment

Please sign in here or register here to comment. It is free to register and only takes a minute or two.

News sponsored by:

The Citywire Guide to Investment Trusts

In this guide to investment trusts, produced in association with Aberdeen Asset Management, we spoke to many of the leading experts in the field to find out more.

Watch Now

Today's articles

Tools from Citywire Money

From the Forums

+ Start a new discussion

Weekly email from The Lolly

Get simple, easy ways to make more from your money. Just enter your email address below

An error occured while subscribing your email. Please try again later.

Thank you for registering for your weekly newsletter from The Lolly.

Keep an eye out for us in your inbox, and please add to your safe senders list so we don't get junked.


The Accumulator: FTSE see-saws on trade war fears

by Michelle McGagh on Jun 22, 2018 at 14:57

Sorry, this link is not
quite ready yet